Corami Biotech Inc.
Biotech TN
$1M raised
Tetrous, Inc.
Biotech Sherman Oaks, CA
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Biotech
- Headquarters
- Sherman Oaks, CA
- Street
- 14930 Ventura Blvd., Suite 325
- Zip
- 91324
Offering
- Total offering
- $4M
- Amount sold
- $1.7M
- First sale
- Apr 8, 2026
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 64
How this filing compares
Ranked #19 of 47 Biotech filings in April 2026 by offering amount.
Median Biotech filing in April 2026: $3M. This offering is 1.3× the median.
Other California filings this week: 444 Capital - D'Amelio Family Fund I, LP, Angeles Private Markets Fund 6 LP, AQT Capital Fund, LP, C1 Group LLC, Camden Bonds Plus Fund, LLC
Leadership
Bradley E. Patt — Executive Officer (also: Director)
Gunnar Andersson — Director
Simon Berry — Director
John Bojanowski — Director
Matthew Muscio — Director
Jan Iwanczyk — Director
Frank Philips — Director
Andy Carter — Director
Nikhil Verma — Director
Filing details
Tetrous, Inc. filed a Form D with the SEC on April 22, 2026.
Other newest Biotech companies
Hepion Pharmaceuticals, Inc.
Biotech NJ
$700k raised
Terremoto Biosciences, Inc.
Biotech CA
$108.6M raised
Visor Health Inc.
Biotech KY
$3M raised
Avivomed Inc.
Biotech MN
$12M raised
Haylex Laboratories Inc.
Biotech TX
$1.5M raised
Other newest companies in California
444 Capital - D'Amelio Family Fund I, LP
Services CA
$25M raised
Angeles Private Markets Fund 6 LP
Services CA
Amount undisclosed
AQT Capital Fund, LP
Services CA
Amount undisclosed
C1 Group LLC
Fintech CA
$2.7M raised
Camden Bonds Plus Fund, LLC
Services CA
Amount undisclosed
Cervin Ventures Affiliates Fund VI, L.P.
Services CA
Amount undisclosed